Feuerstein T J, Weinheimer G, Lang G, Ginap T, Rossner R
Neuropharmakologisches Labor der Neurologischen Universitätsklinik, Freiburg, Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1993 Nov;348(5):549-51. doi: 10.1007/BF00173218.
The interaction of ascorbic acid and of dehydroascorbic acid with acetylcholine (ACh) release in rabbit caudate nucleus was investigated. The presence of ascorbic acid in the superfusion medium decreased the release of ACh evoked by N-methyl-D-aspartate (NMDA), but not by electrical stimulation. The pH of the buffer was always maintained at 7.4. Inhibition occurred even at 570 mumol/l ascorbic acid, a concentration which is widely employed in transmitter release experiments. In vivo this concentration may be reached extracellularly in brain tissue. Both ascorbic acid and dehydroascorbic acid inhibited the NMDA-evoked ACh release to the same degree in a non-competitive manner. The nearly identical action of ascorbic acid and dehydroascorbic acid makes a mode of action by lipid peroxidation or by redox phenomena unlikely. The mechanism of action underlying the described effects is unknown.
研究了抗坏血酸和脱氢抗坏血酸与兔尾状核中乙酰胆碱(ACh)释放的相互作用。在超灌流介质中存在抗坏血酸会降低由N-甲基-D-天冬氨酸(NMDA)诱发的ACh释放,但不会降低电刺激诱发的ACh释放。缓冲液的pH值始终保持在7.4。即使在570μmol/L抗坏血酸(该浓度在递质释放实验中广泛使用)时也会出现抑制作用。在体内,脑组织的细胞外可能会达到这个浓度。抗坏血酸和脱氢抗坏血酸均以非竞争性方式同等程度地抑制NMDA诱发的ACh释放。抗坏血酸和脱氢抗坏血酸几乎相同的作用使得脂质过氧化或氧化还原现象的作用模式不太可能。所述效应的潜在作用机制尚不清楚。